Rolling Green Cannabis

In October 2026, Rolling Green Cannabis concentrated 76.40% of sales in Flower and 23.60% in Pre-Roll, with Flower down 39.15% year over year and 17.40% month over month, while Pre-Roll declined 15.64% year over year but rose 10.77% month over month. Against a brand-level sales contraction of 34.87% year over year and an 11.55% decline in average price, this mix signals dependence on Flower that is shrinking faster than the brand overall, even as Pre-Roll gains monthly traction; in New York Flower, the brand sits at rank 9, indicating middle-tier placement despite the heavier Flower exposure. The pattern implies a tactical pivot opportunity: lift the growing Pre-Roll contribution while containing Flower’s sharper declines to rebalance revenue volatility.

Pre-Roll’s 10.77% month-over-month increase alongside Flower’s 17.40% month-over-month drop suggests category substitution is underway at current price tiers, amplified by the 11.55% year-over-year decrease in average price and a 76.40% revenue weight still anchored in Flower. With a 38.36% 24-month sales gain but a 34.87% year-over-year decline, the mix indicates that sustaining rank 9 in New York Flower will likely require shifting 5–10 percentage points of share toward Pre-Roll if the monthly growth trend persists, because the faster-falling Flower base is dragging aggregate performance while the smaller Pre-Roll segment is the only category showing near-term momentum; the implication is a repositioning toward value-oriented Pre-Rolls to stabilize share without surrendering core Flower presence.